News
Promoting Health and Recovery: Daily Care for Leukemia Patients
Ensuring a safe and comfortable treatment experience for leukemia patients involves meticulous daily care, including environmental sanitation, personal hygiene, nutrition, and appropriate exercise. This guide provides essential tips for effective daily care to support recovery.
NS7CAR-T Cell Therapy Shows Promise for Treating R/R T-ALL/LBL
A recent study highlights the efficacy and safety of NS7CAR-T cell therapy in treating relapsed or refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) and T-cell lymphoblastic lymphoma (R/R T-LBL). This therapy offers new hope for patients with these aggressive forms of cancer.
Groundbreaking Results of CD7-Targeted CAR-T Therapy for T-ALL and T-LBL
A recent study highlights the promising results of CD7-targeted chimeric antigen receptor (CAR) T cell therapy in treating patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).
Coverage of the 2024 ASH Annual Meeting and Exposition
The 66th Annual Meeting of the American Society of Hematology (ASH) will be held from December 7-10, 2024, at the San Diego Convention Center, showcasing groundbreaking research and advancements in hematology.
Announcing the 2024 Annual Lu Daopei Hematology Forum in August
The 12th Annual Lu Daopei Hematology Forum is set to take place on August 23-24, 2024, at the Beijing International Convention Center. Join us for insightful discussions and the latest advancements in hematology.
New Hope in Cancer Treatment: TILs Therapy Emerges as the Next Frontier
Despite the ongoing challenges in industrialization and commercialization, CAR-T therapy's limitations are being addressed by a promising new approach: Tumor-Infiltrating Lymphocyte (TIL) therapy. This breakthrough heralds a new era in the fight against solid tumors.
Are Cellular Therapies the Future of Autoimmune Disease?
A revolutionary treatment for cancers may also be able to treat and reset the immune system to provide long-term remission or possibly even cure certain autoimmune diseases.
2023 ASH Opening | Dr. Peihua Lu Presents CAR-T for Relapsed /Refractory AML Research
ASH 2023|"The Voice of Lu Daopei" sings on the international stage
